Publication: 3316

CHIO3: Chemotherapy combined with immune checkpoint inhibitor for operable stage IIIA/B non-small cell lung cancer (AFT-46)
   Google Scholar   
Citation:
J Thorac Oncol vol 16 (3S) S648 P79.06
Meeting Instance:
IASLC (WCLC) 2020
Year:
2021
Type:
Abstract
Sub type:
Funding:
AFT
Endpoint:
No-Endpoint
Analysis:
Trial-Description-Only
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
Astra-Zeneca  
Grants:
AFT  
Corr. Author:
 
Authors:
                 
Networks:
CA249, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-NC010, VA009   
Study
AFT-46
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: